Switch-Maintenance Gemcitabine After First-Line Chemotherapy In Patients With Malignant Pleural Mesothelioma

Clinical trial NCT05660616 · COMPLETED

Trial details

NCT number: NCT05660616
Sponsor: Ain Shams University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Pleural Mesothelioma

Start date: 2023-04-01
Primary completion: 2024-04-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.